Endocrine Signaling
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Hormonal Regulation of Blood Pressure
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Intracellular Hormone Receptors
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Lynley K Lewis1, Timothy G Yandle1, Philip J Hilton1
1From the Christchurch Heart Institute (L.K.L., T.G.Y.) and Department of Medicine (E.J.B., M.G.N.), University of Otago-Christchurch, Christchurch, New Zealand; Department of Medicine, St Thomas' Hospital, London, United Kingdom (P.J.H.); and Division of Toxicology, Canterbury Health Laboratories, Christchurch, New Zealand (B.P.J.).
No abstract available in PubMed .